Article Details
Retrieved on: 2021-01-27 17:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Edible Antibodies -- Seattle-based Lumen Bioscience snagged $14.5 million from CARB-X to fund the development of an oral monoclonal antibody ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here